Federated Hermes
ECYT

Federated Hermes’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Federated Hermes’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-233
Closed -$3K – 2380
2018
Q2 		$3K Buy
+233
New +$2.77K ﹤0.01% 2095
2016
Q2 		– Sell
-1,352
Closed -$4K – 2236
2016
Q1 		$4K Hold
1,352
– – ﹤0.01% 1922
2015
Q4 		$5K Buy
1,352
+755
+126% +$3.48K ﹤0.01% 1889
2015
Q3 		$3K Buy
+597
New +$3.12K ﹤0.01% 1848

Other funds holding ECYT

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Federated Hermes's ECYT Position: Q3 2018 in Review

Federated Hermes sold out of Endocyte, Inc. Common Stock (ECYT) in Q3 2018, closing a stake of 233 shares — an estimated $3K sold.

Federated Hermes first reported a position in ECYT in Q3 2015 and held it in 4 quarters. The position peaked at $5K in Q4 2015. 139 funds tracked by Wall St. Rank hold ECYT as of Q3 2018.

  • Federated Hermes reported no remaining Endocyte, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Federated Hermes sold 233 Endocyte, Inc. Common Stock shares in Q3 2018, an estimated $3K.
  • Federated Hermes first reported a position in Endocyte, Inc. Common Stock in Q3 2015 and held it in 4 quarters.
  • Federated Hermes's Endocyte, Inc. Common Stock position peaked at $5K in Q4 2015.
  • 139 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q3 2018.

Based on Federated Hermes's 13F filing for Q3 2018, filed 13 Nov 2018.